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Abstract
Background: Patients with sickle cell disease have increased tendency to develop frequent and severe infections, 
especially of bones and urinary tract.
Objective: The knowledge of antimicrobial sensitivity pattern of common etiological agents will serve as a guide to 
empiric treatment while results of urine culture and sensitivity are being awaited.
Materials and Methods: Antimicrobial sensitivity test was carried out on bacterial isolates from the urine of febrile 
children with sickle cell anemia (SCA) and children with HbAA in Maiduguri. Urine specimens were collected and 
cultured by standard methods. Sensitivity to 15 antimicrobials (based on availability of sensitivity disc) was tested using 
the disc-diffusion technique of stokes.
Results: Significant bacteriuria was obtained from 65 (26%) of the 250 children with SCA and 51 (20.4%) of the 250 
controls. The isolates were E. coli, Klebsiella, Coliforms, Proteus, Staph aureus and Salmonella. Sensitivity was highest 
to 3rd generation cephalosporins, followed by the quinolones: ciprofloxacin (86.2%), ofloxacin (83.1%), and peflacine 
(73.8%). Sensitivity of the organisms to some of the commonly used antibiotics like ampicillin, cotrimoxazole, and 
nalidixic acid was generally low. In general, the pattern of bacteriuria and their sensitivity in the SCA group was similar 
to the pattern in the control group.
Conclusion: Etiological agents of childhood urinary tract infections (UTI) in this environment are resistant to most 
of the drugs commonly recommended for its treatment. Amoxicillin/clavulanic acid, cefuroxime, and gentamicin, are 
recommended as first-line drugs for treatment of UTI while awaiting results of culture and sensitivity. Ceftriaxone and 
ceftazidime should be reserved for case of non response to first-line drugs and severe infections.
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Introduction
Urinary tract infection (UTI) is a significant cause of 
morbidity in childhood, and children with sickle cell 
disease (SCD) have been observed to have an increase 
risk of UTI. [1-4] Delay in instituting appropriate treatment 
may lead to formation of scar and subsequent renal 
impairment.[5,6] Knowledge of antibiotic sensitivity pattern 
of the common etiological agents is of great importance. 
The knowledge will also serve as a guide to first-line 
treatment while the results of culture and sensitivity are 
being awaited. Prompt treatment will reduce the risk of 
renal scaring and other sequelae of UTI in sickle cell 
anemia (SCA) individuals such as precipitation of crisis 
and fatal septicemia.[7,8]
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This study is relevant since there is no previous report to 
guide antibiotic therapy for UTI in children with SCA in 
this environment. The study was therefore designed to 
determine the antibiotic sensitivity pattern of bacterial 
agents isolated from the urine of febrile SCA children seen 
at University of Maiduguri Teaching Hospital and State 
Specialist Hospital Maiduguri, North-Eastern Nigeria.
Materials and Methods
The study population consisted of 250 patients with SCA 
(Hemoglobin SS) aged 6 months to 15 years presenting with 
fever (temperature ≥ 37.5°C) at the Pediatric Consultants 
Clinics or Children Emergency Wards of both the Teaching 
Hospital and the State Specialist Hospital, Maiduguri, 
between October 2005 and January 2008. Equal number 
(250) of children with HbAA matched for age and sex with 
fever were enrolled as controls. Children clinically suspected 
to have conditions with increased risk of UTI such as 
glomerulopathy, nephrotic syndrome, severe malnutrition, 
or obstructive uropathies were excluded from the study.[9,10] 
Children who had history of antibiotic intake in the last 7 days 
and dehydrated children were also excluded from the study.
After detailed history and clinical examination was carried 
out on each patient, midstream urine specimen were 
carefully collected in children that have achieved bladder 
control, while suprapubic bladder aspiration was carried out 
in infants. The urine specimens were put into two sterile 
Universal bottles; one was used for dipstick urinalysis using 
multistix 10G (Bayer Corporation 2501 NW 34th Place 
Pompano Beach, Florida, USA) for the nitrite test, and the 
other specimen were taken immediately to the microbiology 
department of the Teaching Hospital for culture. Urine 
specimen collected at the State Specialist Hospital were kept 
in refrigerator at 4°C for the period of the clinic (2-3 h) and 
later transported immediately to the Teaching Hospital’s 
microbiology department, usually 10 to 20 minutes’ drive. 
The specimens were cultured immediately by inoculation 
into blood and MacConkey agar and incubated at 37°C for 
48–72 h.[11] Samples showing at least 105 colony-forming 
units of bacteria per mL were considered to indicate 
significant bacteriuria.[12] Identification of the organisms 
to species level was via systematic bacteriological and 
biochemical test using standard techniques.[13]
Antimicrobial sensitivity tests were performed using the 
dick-diffusion technique of stokes,[14] using Oxoids miltidiscs. 
The Oxoids sensitivity discs were impregnated with ampicillin 
2 µg, cephalexin 10 µg, ciprofloxacin 10 µg, erythromycin 
10 µg, Pefloxacin 10 µg, chloramphenicol 10 µg, nalidixic 
acid 30 µg, amoxicillin/clavulanic acid 10 µg, ceftriaxone 30 
µg, ofloxacin 10  µg, cotrimoxazole 10 µg, gentamicin 10 µg, 
cefuroxime 30 µg, ceftazidime 30 µg, and amoxicillin 10 µg. 
The control method was set up using Oxford Staphylococcus 
aureus NCTC 1048 for Gram-positive bacteria and Oxford 
Escherichia coli NCTC 10896 for Gram-negative bacteria. 
The organisms were regarded as sensitive when the zone of 
inhibition measured using a calibrated ruler was compared 
to the control bacteria.
Results
The mean age of the children with SCA was 5.6 ± 4.4 years, 
while the mean age of the controls was 5.4 ± 4.3 years. 
There were 145 boys and 105 girls in the SCA group and 
the HbAA control group, giving a male:female ratio of 
1.4:1. The prevalence of bacteriuria in the group with 
SCA was 26.0% (65 of 250) and was 20.4% (51 of 250) in 
the controls. The most frequently isolated organism in the 
SCA and the control group was E. coli, 18 (27.7%) and 
19 (37.3%), respectively. Other organisms in the SCA group 
were Klebsiella 24.6%, Proteus 17%, Staph aureus 13.8%, 
Coliforms 13.8%, and Salmonella 3.1%, while in the control 
group were as follows; Klebsiella 11.8%, Proteus 3.9%, Staph 
aureus 21.6%, and Coliforms 25.4%.
Table 1 shows the sensitivity of the isolates from SCA 
patients. The drugs associated with least sensitivity were 
erythromycin 10.8%, ampicillin 16.9%, cotrimoxazole 21.5%, 
and nalidixic acid 23.1%. Sensitivity was generally higher 
to the 3rd generation cephalosporins, especially ceftriaxone 
89.2%, followed by the quinolones; ciprofloxacin, ofloxacin, 
and peflacine (86.2%, 83.1%, and 73.8%, respectively), and 
Table 1: Antimicrobial sensitivity pattern of urinary isolates among SCA children
Isolates Sensitivity (%)
AMP CPX CIP OFL COT ERY PEF CHL GEN CXM NAL AUG CRO AML CAF
E. coli n = 18 5.6 22.2 94.4 83.3 16.7 16.7 66.7 50.0 61.1 55.6 38.9 38.9 83.3 33.3 72.2
Klebsiella n = 16 25.0 50.0 93.8 81.3 25.0 0 87.5 50.0 31.3 68.8 37.5 43.8 93.8 31.3 81.3
Proteus spp n – 11 18.2 27.3 72.7 81.8 18.2 0 63.6 36.4 45.5 63.6 18.2 9.1 90.9 0 81.8
Staph aureus n = 9 33.3 55.6 77.8 77.8 44.4 22.2 66.7 33.3 44.4 44.4 0 44.4 88.9 33.3 55.6
Coliforms n = 9 11.1 55.6 77.8 88.9 0 22.2 88.9 55.6 55.6 55.6 0 44.4 88.9 22.2 88.9
Salmonella spp n=2 0 0 100 100 50.0 0 50.0 100 50.0 50.0 0 100 100 50.0 100
Overall sensitivity n=65 16.9 38.5 86.2 83.1 21.5 10.8 73.8 46.2 47.7 58.5 23.1 38.5 89.2 26.2 76.9
AMP = Ampicillin; ERY = Erythromycin; NAL = Nalidixic Acid; CPX = Cephalexin; PEF = Pefloxacin; AUG = Amoxicillin/clavulanic acid; CIP = Ciprofloxacin; 
CHL = Chloramphenicol; CRO = Ceftriaxone; OFL = Ofloxacin; GEN = Gentamicin; AML = Amoxicillin; COT = Cotrimoxazole; CXM = Cefuroxime; 
CAF = Ceftazidime
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for second generation cephalosporin cefuroxime was 58.2%, 
comparable to chloramphenicol, which was 46.2%.
Table 2 shows the sensitivity of the microbial isolates in 
the controls. Those associated with least sensitivity were 
erythromycin 10.8%, ampicillin 16.9%, cotrimoxazole 
21.5%, and nalidixic acid 23.1%. Sensitivity to amoxicillin 
was 26.2%, but when augmented with clavulanic acid it was 
enhanced to 38.5%. Sensitivity to gentamicin was 47.7%.
Discussion
SCA patients are prone to infections, and UTI is a known 
morbidity in them. Since several workers have reported 
increased risk of UTI in this group of individual, it is, 
therefore, necessary to have a guide to appropriate first-line 
drugs to institute early treatment.
This study reports the sensitivity of urinary isolates to 15 
antimicrobials. The spectrum of isolates from the SCA 
children was grossly similar to that from the control 
group. In the SCA group, most isolates were resistant to 
ampicillin, which is similar to finding by Brown et al.[15] 
in Ibadan and by Elbashier and Badu[3] in Saudi Arabia. 
There was also a high level of resistance to cotrimoxazole 
in the present study, which is apparently in agreement 
with the study done in Ibadan.[16] Other workers in 
Nigeria[9,17,18] have reported similar level of resistance of 
pathogens isolated from the urinary tract to cotrimoxazole. 
In a study by Obaseiki-Ebor[19] in Benin, Nigeria, 80% of 
E. coli isolates and 74% of Klebsiella isolates were resistant 
to cotrimoxazole. Adeyemo et al.[16] in Ibadan observed 
that 100% of E. coli isolates and over 90% of Klebsiella 
isolates were resistant to cotrimoxazole and ampicillin.[16] 
In a study in Saudi Arabia, it was reported that E. coli 
and Klebsiella were highly susceptible to cotrimoxazole.[3] 
The reason for the contrast may be that cotrimoxazole 
is not a common on-the-counter drug in Saudi Arabia; 
meanwhile, it is very common in Nigeria. Thus, resistance 
easily develops.
In this study, there was a high level of resistance to 
amoxicillin, but sensitivity was improved when augmented 
with clavulanic acid, which was in keeping with finding 
by Brown et al.[15] Amoxicillin/clavulanic acid improved 
sensitivity by 12.3% in this study, while in Ibadan study 
it improved by 22.3%. With the high level of resistance 
to common antimicrobials observed in this study, it will 
seem unsafe to recommend the use of cotrimoxazole, 
ampicillin, amoxicillin, and nalidixic acid as the first-line 
drugs in empirical treatment for UTI in this environment. 
There was relatively lower sensitivity of the isolates to 
cefuroxime compared to report by other workers.[3,16] This 
falling in sensitivity even to cephalosporins may mean that 
the organisms are developing resistance even in the normal 
inhibitory concentration of the drugs or there is increasing 
abuse or misuse of these drugs.
Finding of high sensitivity to quinolones (pefloxacin, 
ciprofloxacin, and ofloxacin) in this study is similar to 
finding by Brown et al.[15] and Adeyemo et al.[16] The 
quinolones are generally not recommended in young 
children. They may be of use in multi-drug resistant 
infections.[20] This practice was demonstrated in a 
Pseudomonas infection treated with quinolones in 
Ibadan.[15] While the risk of joint damage from quinolones 
had caused clinicians to exercise caution in prescribing 
these agents in children, close monitoring of pediatric 
patients receiving ciprofloxacin, a quinolone, has failed 
to reveal cartilage toxicity.[21] Other studies evaluating 
joint changes using magnetic resonance imaging, 
skeletal function tests, high-velocity laboratory testing, 
and physical examinations have revealed no abnormal 
development.[20-22] In the case of pefloxacin whose use 
has been associated with arthropathy, it is reversible and 
subsides after the drug is discontinued.[24] In addition, the 
incidence of arthropathy following the use of this drug 
seems to be age-related, being greater when the drug is 
first used between 15 and 20 years of age.[23] Therefore, 
it seems relatively safe to use it in multi-drug resistant 
infections below the age of 15 years; more so, since the 
review of available data on the pharmacokinetics of the 
quinolones in children suggest no risk of nephropathy, 
it may be considered a potentially useful drug in the 
treatment of childhood UTI.[24]
Table 2: Antimicrobial sensitivity pattern of urinary isolates among controls
Isolates Sensitivity (%)
AMP CPX CIP OFL COT ERY PEF CHL GEN CXM NAL AUG CRO AML CAF
E. coli n = 19 10.5 31.6 78.9 78.9 26.3 5.3 68.4 42.1 63.2 57.9 42.1 15.8 100 21.1 84.2
Klebsiella n = 6 16.7 33.3 100 100 16.7 0 33.3 33.3 66.7 50.0 16.7 16.7 100 0 100
Proteus spp n = 2 0 0 100 100 0 0 50.0 50.0 100 100 0 0 100 0 100
Staph aureus n = 11 9.1 45.5 90.9 63.6 27.3 36.4 72.7 72.7 81.8 63.6 54.5 63.6 100 9.1 90.9
Coliforms n = 13 7.7 23.1 100 84.6 0 7.7 53.8 69.2 61.5 53.8 38.5 30.8 92.3 15.4 84.6
Overall sensitivity n = 51 9.8 31.4 90.2 80.4 17.6 11.8 60.8 54.9 68.6 58.8 39.2 29.4 98.0 13.7 88.2
AMP = Ampicillin; ERY = Erythromycin; NAL = NalidixicAcid; CPX = Cephalexin; PEF = Pefloxacin; AUG = Amoxicillin/clavulanic acid; CIP = Ciprofloxacin; 
CHL = Chloramphenicol; CRO = Ceftriaxone; OFL = Ofloxacin; GEN = Gentamicin; AML = Amoxicillin; COT = Cotrimoxazole; CXM = Cefuroxime; 
CAF = Ceftazidime
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The greater sensitivity to ceftriaxone in this study is similar 
to findings by Elbashier and Badu[3] in Saudi Arabia where 
they found 93%, sensitivity of E. coli and Klebsiella to this 
drug. The explanation for this high sensitivity of this drug 
to urinary isolate in this environment may be that the 
drug cannot easily be abused because of it cost and route 
of administration. In this environment, most parents 
cannot afford the drug even when it is prescribed. Further 
implication of this high sensitivity means that the drug 
should be prescribed only when it is seriously indicated, 
either in a severe infection or based on sensitivity testing, so 
as to preserve its sensitivity to bacterial agents causing UTI.
Conclusion
There is similarity in the pattern of bacteriuria and 
antimicrobial sensitivity and resistance observed among 
SCA and control group; this study calls for a review of the 
drugs routinely used as first-line in the treatment of UTI in 
this environment. Amoxicillin/clavulanic acid, cefuroxime, 
and gentamicin are recommended for empiric treatment drug 
while awaiting the results of urine culture and sensitivity. 
Because of cost and non-availability of oral formulations, 
ceftriaxone and ceftazidime should be reserved for case of 
non-response to first-line drugs or in severe infections. There 
is a need to review the indication for the use of quinolones, 
particularly in infections caused by multi-drug resistant 
organisms, when third-generation cephalosporins cannot be 
purchased because of cost, especially in a developing world 
like Nigeria. Consideration should be given to pefloxacin and 
ciprofloxacin as potential drugs for the treatment of UTI in 
such cases, though the effect of quinolones on growing end 
of bones may limit their use.
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